01—Abstract
Summary
Summary of the 8-K filed May 7, 2025. Cited figures are marked; the original filing is the authoritative source.
Emerson reported fiscal Q2 2025 (quarter ended March 31, 2025) results with net sales up 1% to $4,432Ma and underlying sales up 2%, while underlying orders grew 4%.
Adjusted segment EBITA margin expanded 200 bps to 28.0%, and adjusted EPS rose 9% to $1.48b. GAAP EPS fell 9% to $0.86, reflecting AspenTech transaction costs, discrete taxes, and lower intangibles amortization offsets. Operating cash flow rose 13% to $825M and free cash flow rose 14% to $738M.
The quarter marked the close of Emerson's portfolio transformation: the AspenTech buy-in was completed March 12, 2025, eliminating noncontrolling interests (which fell from $5,873M to $17Mc on the balance sheet). Management also concluded its strategic review of Safety & Productivity and decided to retain the segment. The funding of the buy-in is visible in the balance sheet, with short-term borrowings jumping to $6,187M and cash falling to $1,887M from $3,588M at September 30, 2024.
FY2025 guidance changes are mixed: net sales growth is raised to ~4%, adjusted EPS is raised to $5.90d–$6.05, but GAAP EPS is lowered to $4.05–$4.20 due to transaction-related costs. Operating cash flow guidance is set at $3.5–$3.6B and free cash flow at $3.1–$3.2B, after roughly $0.2B of transaction-related headwinds. The company expects to return about $2.3B to shareholders in FY2025 through $1.1B of buybacks and $1.2B of dividends.
02—Key points
Key Highlights
- Net sales of $4,432M (+1% reported, +2% underlying); underlying orders +4%, a positive leading indicator for growth.
- Adjusted segment EBITA margin expanded 200 bps to 28.0%, with Software and Control at 32.3% and Control Systems & Software at 35.0%; Test & Measurement segment earnings swung from a loss to a 24.2% margin.
- GAAP EPS fell 9% to $0.86 while adjusted EPS rose 9% to $1.48; the gap reflects $168M of acquisition/divestiture fees and $0.09 of AspenTech-related discrete taxes.
- AspenTech buy-in completed March 12, 2025, eliminating the noncontrolling interest and making AspenTech fully owned; this removed roughly $7.2B of cash outflow for the purchase of the noncontrolling interest in the six-month period.
- Safety & Productivity review concluded with a decision to retain the business, ending potential divestiture speculation; segment sales fell 7% (6% underlying).
- FY2025 guidance: net sales ~4%, adjusted EPS raised to $5.90–$6.05, GAAP EPS lowered to $4.05–$4.20, and free cash flow $3.1–$3.2B.
- Balance sheet leverage increased: short-term borrowings rose to $6,187M and long-term debt to $8,176M, while cash declined to $1,887M, making debt maturities and refinancing a key investor focus.
03—Questions
Frequently Asked Questions
Why did GAAP EPS decline while adjusted EPS grew?
GAAP EPS fell to $0.86 from $0.95, mainly due to $168M of acquisition and divestiture fees and related costs tied to the AspenTech transaction, plus $0.09 per share of discrete taxes. Adjusted EPS excludes these items and amortization, so it rose 9% to $1.48 on stronger segment margins and lower amortization.
What does the AspenTech buy-in mean for Emerson's financials going forward?
Emerson now owns 100% of AspenTech, so the noncontrolling interest that previously absorbed a share of AspenTech earnings (about $55M in Q2 2025 at the prior level) has effectively ended. Future earnings attributable to common stockholders should be larger relative to consolidated results, but the company funded the roughly $7.2B purchase with debt and cash, which increased leverage.
Is Emerson's cash generation still strong despite the transaction?
Yes. Operating cash flow grew 13% to $825M and free cash flow grew 14% to $738M in Q2. Full-year guidance of $3.1–$3.2B free cash flow is maintained despite roughly $0.2B of transaction-related headwinds, and the company still plans about $2.3B of shareholder returns in FY2025.
What is the outlook for the rest of fiscal 2025?
Management raised full-year net sales growth to about 4% and adjusted EPS to $5.90–$6.05, while lowering GAAP EPS to $4.05–$4.20 because of transaction costs. For Q3, guidance calls for net sales growth of 4.5%–5.5% and adjusted EPS of $1.48–$1.52.
Did Emerson decide to sell the Safety & Productivity segment?
No. Management concluded that retaining the business delivers the best value for shareholders, citing its industry-leading margins and cash flow. Segment sales fell 7% in the quarter (6% underlying), so investors should watch whether its performance improves now that the strategic review is complete.
04—Continue